JP2011500697A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500697A5
JP2011500697A5 JP2010530054A JP2010530054A JP2011500697A5 JP 2011500697 A5 JP2011500697 A5 JP 2011500697A5 JP 2010530054 A JP2010530054 A JP 2010530054A JP 2010530054 A JP2010530054 A JP 2010530054A JP 2011500697 A5 JP2011500697 A5 JP 2011500697A5
Authority
JP
Japan
Prior art keywords
methyl
phenyl
bipyrrolidinyl
amide
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010530054A
Other languages
English (en)
Japanese (ja)
Other versions
JP5380455B2 (ja
JP2011500697A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/079763 external-priority patent/WO2009052068A1/en
Publication of JP2011500697A publication Critical patent/JP2011500697A/ja
Publication of JP2011500697A5 publication Critical patent/JP2011500697A5/ja
Application granted granted Critical
Publication of JP5380455B2 publication Critical patent/JP5380455B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010530054A 2007-10-17 2008-10-14 置換されたn−フェニル−ビピロリジン尿素及びその治療上の使用 Expired - Fee Related JP5380455B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98060607P 2007-10-17 2007-10-17
US60/980,606 2007-10-17
PCT/US2008/079763 WO2009052068A1 (en) 2007-10-17 2008-10-14 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof

Publications (3)

Publication Number Publication Date
JP2011500697A JP2011500697A (ja) 2011-01-06
JP2011500697A5 true JP2011500697A5 (enExample) 2011-12-01
JP5380455B2 JP5380455B2 (ja) 2014-01-08

Family

ID=40248052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010530054A Expired - Fee Related JP5380455B2 (ja) 2007-10-17 2008-10-14 置換されたn−フェニル−ビピロリジン尿素及びその治療上の使用

Country Status (24)

Country Link
US (1) US8222290B2 (enExample)
EP (1) EP2215058B1 (enExample)
JP (1) JP5380455B2 (enExample)
KR (1) KR20100082349A (enExample)
CN (1) CN101903341B (enExample)
AT (1) ATE534625T1 (enExample)
AU (1) AU2008312641A1 (enExample)
CA (1) CA2702933C (enExample)
CY (1) CY1112391T1 (enExample)
DK (1) DK2215058T3 (enExample)
ES (1) ES2378011T3 (enExample)
HR (1) HRP20120166T1 (enExample)
IL (1) IL205002A0 (enExample)
MA (1) MA31889B1 (enExample)
MX (1) MX2010003948A (enExample)
MY (1) MY148807A (enExample)
NZ (1) NZ584692A (enExample)
PL (1) PL2215058T3 (enExample)
PT (1) PT2215058E (enExample)
RS (1) RS52221B (enExample)
RU (1) RU2478094C2 (enExample)
SI (1) SI2215058T1 (enExample)
WO (1) WO2009052068A1 (enExample)
ZA (1) ZA201002114B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2212282T1 (sl) * 2007-10-17 2012-01-31 Sanofi Sa Substituirani n-fenil-bipirolidin karboksamidi in njihova terapevtska uporaba
DK2212283T3 (da) 2007-10-17 2011-12-19 Sanofi Sa Substituerede N-phenylbipyrrolidincarboxamider og terapeutisk anvendelse deraf
EP2205558B1 (en) * 2007-10-17 2012-07-25 Sanofi Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators
WO2009151203A1 (ko) * 2008-06-13 2009-12-17 주식회사 엘지화학 발열체 및 이의 제조방법
US10412788B2 (en) 2008-06-13 2019-09-10 Lg Chem, Ltd. Heating element and manufacturing method thereof
KR20090129927A (ko) 2008-06-13 2009-12-17 주식회사 엘지화학 발열체 및 이의 제조방법
AR081908A1 (es) 2010-05-11 2012-10-31 Sanofi Aventis N-heteroaril-espirolactama-bipirrolidinas sustituidas, preparacion y usos terapeuticos de las mismas
TW201206939A (en) 2010-05-11 2012-02-16 Sanofi Aventis Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
JP2013526530A (ja) * 2010-05-11 2013-06-24 サノフイ 置換されたn−フェニルスピロラクタムビピロリジン、その製造及び治療上の使用
AR081034A1 (es) 2010-05-11 2012-05-30 Sanofi Aventis Derivados de n-heteroaril tetrahidro-isoquinolina sustituidos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades del sistema nervioso central
EP2569294B1 (en) * 2010-05-11 2015-03-11 Sanofi Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
JP5766278B2 (ja) 2010-05-11 2015-08-19 サノフイ 置換されたn−アルキルおよびn−アシルテトラヒドロ−イソキノリン誘導体、それらの製造および治療上の使用
WO2011143161A1 (en) 2010-05-11 2011-11-17 Sanofi Substituted n-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof
SG10202010119TA (en) 2010-11-15 2020-11-27 Abbvie Inc NAMPT And Rock Inhibitors
EA023260B1 (ru) * 2011-02-23 2016-05-31 Сувен Лайф Сайенсиз Лимитед Новые соединения в качестве лигандов гистаминовых h-рецепторов

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020507A1 (es) * 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
US7279491B2 (en) * 2002-10-23 2007-10-09 Janssen Pharmaceutica N.V. Phenylpiperidines and phenylpyrrolidines
US7223788B2 (en) * 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
DE10306250A1 (de) * 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE602006010833D1 (de) 2005-03-17 2010-01-14 Lilly Co Eli Pyrrolidinderivate als histamin-h3-rezeptorantagonisten
CN101151244B (zh) * 2005-04-01 2014-09-03 伊莱利利公司 组胺h3受体活性剂、制备和治疗用途
EP2322506A1 (en) * 2005-07-01 2011-05-18 Eli Lilly and Company Histamine H3 receptor agents, preparation and therapeutic uses
US7943605B2 (en) * 2005-10-27 2011-05-17 Ucb Pharma S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
SI2212282T1 (sl) 2007-10-17 2012-01-31 Sanofi Sa Substituirani n-fenil-bipirolidin karboksamidi in njihova terapevtska uporaba
EP2205558B1 (en) 2007-10-17 2012-07-25 Sanofi Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators
DK2212283T3 (da) 2007-10-17 2011-12-19 Sanofi Sa Substituerede N-phenylbipyrrolidincarboxamider og terapeutisk anvendelse deraf

Similar Documents

Publication Publication Date Title
CA2702933A1 (en) Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
RU2010119530A (ru) Замещенные n-фенилпирролидинилметилпирролидинамиды и их терапевтическое применение в качестве модуляторов рецептора н3 гистамина
JP2011500694A5 (enExample)
JP2009541461A5 (enExample)
JP2008110984A5 (enExample)
JP2011500696A5 (enExample)
JP2011524906A5 (enExample)
JP2005526723A5 (enExample)
JP2011500693A5 (enExample)
RU2010119560A (ru) Замещенные n-фенилбипирролидинкарбоксамиды и их терапевтическое применение
NO341591B1 (no) 3-Z-[1-(4-(N-((4-metyl-piperazin-1-yl)-metylkarbonyl)-N-metyl-amino)-anilino)-1-fenyl-metylen]-6-metoksykarbonyl-2-indolinon, tautomerene, diastereomerene, enantiomerene, blandinger derav og saltene derav, og i kombinasjon med en ytterligere farmakologisk aktiv substans, for anvendelse i forebygging eller behandling av fibrose ved revmatoid artritt
RU2012129737A (ru) Замещенные бензамидные производные
JP2017510555A5 (enExample)
NZ600716A (en) Substituted isoquinolinones and quinazolinones
JP2011513305A5 (enExample)
NZ603724A (en) Piperidine derivatives and their use for the treatment of metabolic disorders
JP2007508360A5 (enExample)
RU2010119528A (ru) Замещенные n-фенилбипирролидинкарбоксамиды и их применение в лечебных целях
JP2009527462A5 (enExample)
NZ617334A (en) Cyclopropyl amine derivatives
JP2009537542A5 (enExample)
MX2010001080A (es) Pirrolidin-aril-eteres como antagonistas de receptor de nk3.
NZ598083A (en) New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
RU2008120850A (ru) Соединения и композиции в качестве ингибиторов протеинкиназ
PE20091431A1 (es) Compuestos derivados de azetidinas, su preparacion y su aplicacion en terapeutica